These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33647324)

  • 21. Activation of the calcium-sensing receptor in human valvular interstitial cells promotes calcification.
    Issa H; Hénaut L; Abdallah JB; Boudot C; Lenglet G; Avondo C; Ibrik A; Caus T; Brazier M; Mentaverri R; Zibara K; Kamel S
    J Mol Cell Cardiol; 2019 Apr; 129():2-12. PubMed ID: 30769016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.
    Larivière R; Gauthier-Bastien A; Ung RV; St-Hilaire J; Mac-Way F; Richard DE; Agharazii M
    J Hypertens; 2017 Feb; 35(2):376-384. PubMed ID: 28005706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Inhibits Vascular Calcification Through Sirtuin 3-Mediated Reduction of Mitochondrial Oxidative Stress.
    Feng H; Wang JY; Yu B; Cong X; Zhang WG; Li L; Liu LM; Zhou Y; Zhang CL; Gu PL; Wu LL
    Antioxid Redox Signal; 2019 Jul; 31(1):75-91. PubMed ID: 30829051
    [No Abstract]   [Full Text] [Related]  

  • 25. Calcium isotopes as a biomarker for vascular calcification in chronic kidney disease.
    Dosseto A; Lambert K; Cheikh Hassan HI; Fuller A; Borst A; Dux F; Lonergan M; Tacail T
    Metallomics; 2023 Mar; 15(3):. PubMed ID: 36808527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the calcium-sensing receptor in disorders of abnormal calcium handling and cardiovascular disease.
    Toka HR; Pollak MR
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):494-501. PubMed ID: 24992569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
    Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
    Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone Morphogenetic Proteins 2/4 Are Upregulated during the Early Development of Vascular Calcification in Chronic Kidney Disease.
    Wei X; Wu W; Li L; Lin J; Liu Q; Gan L; Ou S
    Biomed Res Int; 2018; 2018():8371604. PubMed ID: 29850574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular calcium-sensing receptors in the parathyroid gland, kidney, and other tissues.
    Quarles LD
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):349-55. PubMed ID: 12815330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia.
    Kaesler N; Goettsch C; Weis D; Schurgers L; Hellmann B; Floege J; Kramann R
    Nephrol Dial Transplant; 2020 Jan; 35(1):65-73. PubMed ID: 30715488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
    Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
    Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
    Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J
    J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apelin: A novel inhibitor of vascular calcification in chronic kidney disease.
    Han X; Wang LY; Diao ZL; Liu WH
    Atherosclerosis; 2016 Jan; 244():1-8. PubMed ID: 26581047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of purinergic P2X
    Lajdova I; Oksa A; Horvathova M; Spustova V
    J Physiol Pharmacol; 2017 Oct; 68(5):779-785. PubMed ID: 29375053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease.
    Neven E; Bashir-Dar R; Dams G; Behets GJ; Verhulst A; Elseviers M; D'Haese PC
    J Bone Miner Res; 2015 Dec; 30(12):2313-24. PubMed ID: 26108730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
    Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney disease.
    Quarles LD
    Kidney Int Suppl; 2005 Jul; (96):S24-8. PubMed ID: 15954947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease.
    Ito S; Higuchi Y; Yagi Y; Nishijima F; Yamato H; Ishii H; Osaka M; Yoshida M
    J Leukoc Biol; 2013 Jun; 93(6):837-45. PubMed ID: 23362306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Omata M; Fukagawa M; Kakuta T
    Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.